Skip Navigation

This Article
Right arrow Print PDF (3605K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (73)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Ohtani, K.
Right arrow Articles by Hinuma, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohtani, K.
Right arrow Articles by Hinuma, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1989, Vol. 17, No. 4 1589-1604
© 1989


MOLECULAR BIOLOGY

Electroporation: application to human lympboid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I

Kiyoshi Ohtani+, Masataka Nakamura*,+, Shigeru Saito§, Kinya Nagata1, Kazuo Sugamura1 and Yorio Hinuma#

Institute for Virus Research, Kyoto University Kyoto 606 Japan 1Department of Bacteriology, Tohoku University School of Medicine Sendai 980, Japan

*To whom correspondence should be addressed

Received October 31, 1988. Accepted January 24, 1989.

Conditions were developed for stable introduction of foreign DNA into human lymphoid cell lines by electroporation. To introduce stably the p40 gene of human T-cell leukemia virus type I (HTLV-I) into the human lymphoid cell line Jurkat, the p40 expressing plasmid, pMAXRHneo-I, which carries the neo resistant gene, was transfected into Jurkat cells at a voltage of 2500 V and capacitance of 21.7 µE, and stable transformants were screened for neo (G418 resistance. The frequency of transformants was more than one per 2 x 105 cells used initially. Clones that were resistant to G418 were shown to have the p40 gene integrated into the host genome and to express mRNA and protein from the introduced plasmid. Expression of p40 in the transformed Jurkat cells was also confirmed by testing the trans-activating effect of HTL enhancer by p40. High frequencies of stable transformations of 10–4 to 10–6 were also reproducibly obtained by electroporation of the human T cell lines HSB-2 and TALL-1, a human B cell line Raji, a human monocytic cell line U937, and a human erythroleukemia cell line K562. These results demonstrate that electroporation is a very efficient method for introducing foreign DNA into human lymphoid cell lines.


+Present address: Department of Bacteriology, Tohuku University School of Medicine, Sendai 980 Japan

§Department of Obstetrics and Gynecology, Nara Medical University, Kashihara 840 Japan

#Shionogi Institute for Medical Science, Settsu-shi, Osaka 566, Japan


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
J. Chen, M. Petrus, B. R. Bryant, V. Phuc Nguyen, M. Stamer, C. K. Goldman, R. Bamford, J. C. Morris, J. E. Janik, and T. A. Waldmann
Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism
Blood, May 15, 2008; 111(10): 5163 - 5172.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hishiki, T. Ohshima, T. Ego, and K. Shimotohno
BCL3 Acts as a Negative Regulator of Transcription from the Human T-cell Leukemia Virus Type 1 Long Terminal Repeat through Interactions with TORC3
J. Biol. Chem., September 28, 2007; 282(39): 28335 - 28343.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Matsuda, A. Almasan, M. Tomita, J.-n. Uchihara, M. Masuda, K. Ohshiro, N. Takasu, H. Yagita, T. Ohta, and N. Mori
Resistance to Apo2 Ligand (Apo2L)/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines
J. Virol., February 1, 2005; 79(3): 1367 - 1378.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mori, Y. Yamada, S. Ikeda, Y. Yamasaki, K. Tsukasaki, Y. Tanaka, M. Tomonaga, N. Yamamoto, and M. Fujii
Bay 11-7082 inhibits transcription factor NF-kappa B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells
Blood, August 13, 2002; 100(5): 1828 - 1834.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mori, H. Sato, T. Hayashibara, M. Senba, T. Hayashi, Y. Yamada, S. Kamihira, S. Ikeda, Y. Yamasaki, S. Morikawa, et al.
Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness
Blood, February 15, 2002; 99(4): 1341 - 1349.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. V. Kibler and K.-T. Jeang
CREB/ATF-Dependent Repression of Cyclin A by Human T-Cell Leukemia Virus Type 1 Tax Protein
J. Virol., March 1, 2001; 75(5): 2161 - 2173.
[Abstract] [Full Text]


Home page
BloodHome page
N. Mori, M. Fujii, K. Iwai, S. Ikeda, Y. Yamasaki, T. Hata, Y. Yamada, Y. Tanaka, M. Tomonaga, and N. Yamamoto
Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells
Blood, June 15, 2000; 95(12): 3915 - 3921.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mori, M. Fujii, S. Ikeda, Y. Yamada, M. Tomonaga, D. W. Ballard, and N. Yamamoto
Constitutive Activation of NF-kappa B in Primary Adult T-Cell Leukemia Cells
Blood, April 1, 1999; 93(7): 2360 - 2368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Ohtani, A. Tsujimoto, T. Tsukahara, N. Numata, S. Miura, K. Sugamura, and M. Nakamura
Molecular Mechanisms of Promoter Regulation of the gp34 Gene That Is Trans-activated by an Oncoprotein Tax of Human T Cell Leukemia Virus Type I
J. Biol. Chem., June 5, 1998; 273(23): 14119 - 14129.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Neuveut, K. G. Low, F. Maldarelli, I. Schmitt, F. Majone, R. Grassmann, and K.-T. Jeang
Human T-Cell Leukemia Virus Type 1 Tax and Cell Cycle Progression: Role of Cyclin D-cdk and p110Rb
Mol. Cell. Biol., June 1, 1998; 18(6): 3620 - 3632.
[Abstract] [Full Text]


Home page
J. Exp. Med.Home page
H. Moriuchi, M. Moriuchi, and A. S. Fauci
Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)-infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I-uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1
J. Exp. Med., May 18, 1998; 187(10): 1689 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Azimi, K. Brown, R. N. Bamford, Y. Tagaya, U. Siebenlist, and T. A. Waldmann
Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappa B site
PNAS, March 3, 1998; 95(5): 2452 - 2457.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Ohbo, N. Takasawa, N. Ishii, N. Tanaka, M. Nakamura, and K. Sugamura
Functional Analysis of the Human Interleukin 2 Receptor [IMAGE] Chain Gene Promoter
J. Biol. Chem., March 31, 1995; 270(13): 7479 - 7486.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.